Blue Cross and Blue Shield of North Carolina’s lawsuit against HHS for failing to pay $130 million owed under the Affordable Care Act (ACA)’s risk corridor program was tossed out by a federal claims judge, saying the agency isn’t required to make those payments annually, according to the National Law Journal.

Personalized medicine can improve a patient's condition—and now a recent study, published in the European Journal of Preventive Cardiology, showed how workouts designed for individuals can prevent heart disease.

Computerized clinical decision support systems (CCDSSs) are meant to improve efficiency, but evidence of such a positive impact is scarce. In a study published by the Journal of the American Medical Informatics Association, researchers evaluated the impact of CCDSSs in emergency department (EDs).

In a move aimed at boosting its population health management portfolio, Siemens Healthineers has announced its intention to acquire Medicalis, a San Francisco and Kitchener, Ontario, Canada-based provider of workflow technology and clinical decision support to radiology groups, imaging centers and hospitals.

Royal Philips, leaders in healthcare technology, have received De Novo clearance from the U.S. Food and Drug Administration (FDA) to market their IntelliSite Pathology Solution. The digital pathology system aids pathologists in improving workflow and is currently the only digital pathology system to receive clearance for primary diagnostic use.

Technology companies like Apple and Google are moving away from their original roots to grow into the realm of healthcare. Their innovative devices have opened to door for improved care on both sides of the healthcare industry and have some believing they might be the next Big Pharma.

Thanks to the 21st Century Cures Act, the Rural Community Hospital Demonstration Program through CMS has been extended for another five years, and eligible hospitals can now apply for the payment program for the first time since 2010. 

Superbowl Sunday, basically a holiday in the U.S., could teach us more than how to tackle the quarterback. In an article by Forbes, Kathy Giusti and Richard G. Hamermesh, Founder of the Multiple Myeloma Research Foundation, and Senior Fellow at Harvard Business School, explain how precision medicine can learn from the NFL.